Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
04:18
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

53rd ERA-EDTA Congress

 

21-24 May 2016 Vienna
FAQs
   
Discussion forum - 53rd ERA-EDTA Congress
    Topic - Genetic diseases and molecular genetics.

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
  
 Thread / Poster  Author  Replies  Last reply
RENAL PHENOTYPES OF DENT DISEASE PATIENTS ACCORDING TO THEIR GENOTYPES  Dalia Dali 1      5/12/2016 2:31:00 PM  
REAL-LIFE PRACTICE IN THE MANAGEMENT OF FABRY DISEASE - PRELIMINARY RESULTS  Fellype Barreto 1      5/11/2016 11:08:00 PM  
THE ROLE OF DNA ANALYSIS IN DIAGNOSIS OF AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE  Jana Reiterova 1      5/11/2016 4:54:00 PM  
DETERMINING TREATMENT PREFERENCE FOR TOLVAPTAN IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD): DEVELOPMENT OF A DISCRETE CHOICE EXPERIMENT (DCE) FOR USE AS A CLINICAL STUDY ENDPOINT  Jennifer Quinn 1      5/11/2016 10:36:00 AM  
DIAGNOSTIC MANAGEMENT OF SUSPECTED ACUTE CYST COMPLICATION IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE  Marie Neuville 1      5/9/2016 10:36:00 PM  
PLASMA SOMATOSTATIN IS NOT ASSOCIATED WITH DISEASE SEVERITY OR RATE OF DISEASE PROGRESSION IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE  A. Lianne 1      5/9/2016 6:30:00 PM  
THE MUTATION-DEPENDENT PATHOGENICITY OF THE NPHS2 R229Q VARIANT  Kalman Tory 1      5/9/2016 6:22:00 PM  
FUNCTIONAL POLYMORPHISM IN THE PROMOTER OF NF-KB1 GENE (-94INS/DELATTG) IS ASSOCIATED WITH A INCREASED RISK FOR CMV INFECTION AFTER KIDNEY TRANSPLANTATION  Francesca Leone 1      5/9/2016 4:02:00 PM  
EFFECT OF CYP3A422, CYP3A53 AND ABCB1 C3435T ON TACROLIMUS METABOLISM IN LEBANESE RENAL TRANSPLANT PATIENTS: A RETROSPECTIVE STUDY  stephanie antoun 1      5/9/2016 10:38:00 AM  
THE IMMUNOLOGICAL ACTIVITY OF LUPUS NEPHRITIS ASSOCIATES WITH THE CONCURRENT DEFICIENCY OF MANNOSE-BINDING LECTIN AND C1Q  Zofia Niemir 1      5/9/2016 1:46:00 AM  
FAMILY SCREENING FOR FABRY DISEASE BASED ON MALE INDEX CASES WITH END-STAGE RENAL DISEASE  Cassiano Silva 1      5/8/2016 10:08:00 PM  
TESTING FOR THE CYTOSINE INSERTION IN THE VNTR OF THE MUC1 GENE IN A COHORT OF ITALIAN PATIENTS WITH AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE  Claudio Musetti 1      5/7/2016 11:29:00 AM  
THE EFFECT OF EVEROLIMUS IN PATIENTS WITH RENAL ANGIOMYOLIPOMA ASSOCIATED WITH TUBEROUS SCLEROSIS COMPLEX  Roser Torra Balcells 1      5/6/2016 12:18:00 PM  
ABERRANT METHYLATED DNA REGIONS LEAD TO LOW ACTIVATION OF CD4 T CELLS WITH A CONSEQUENT IMBALANCE OF THE TH1/TH2 POLARIZATION IN IGA NEPHROPATHY PATIENTS  Fabio Sallustio 1      5/6/2016 11:45:00 AM  
COMPLEMENT SYSTEM ABNORMALITIES IN PATIENTS WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME AND CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME  Kseniya Demyanova 1      5/5/2016 11:35:00 PM  
MIRNA21 EXPRESSION IN URINE AND RENAL TISSUE IN RATS WITH UNILATERAL URETERAL OBSTRUCTION  Marina Parastaeva 1      5/4/2016 3:42:00 PM  
CAN GENETIC RISK SCORES IMPROVE THE PREDICTON POWER FOR MORTALITY OF STANDARD RISK FACTORS IN THE END STAGE KIDNEY DISEASE POPULATION? AN EXPLORATORY STUDY  Belinda Spoto 1      5/4/2016 11:30:00 AM  
PLASMA RENALASE CONCENTRATION BEFORE AND AFTER RADIOFREQUENCY RENAL DENERVATION IN PATIENTS WITH RESISTANT HYPERTENSION: PRELIMINARY RESULTS  Beata Czerwienska 1      4/20/2016 6:10:00 PM  
       




Most viewed poster for this congress
Poster: 547
Visits: 1241
Title: COMPARISON OF PATIENT HAEMOGLOBIN OUTCOMES WITH WEEKLY IRON ADMINISTRATION VS PER SESSION IRON ADMINISTRATION IN ADULT HAEMODIALYSIS PATIENTS
Authors: Joao Fazendeiro , Ricardo Peralta, Carla Felix, Bruno Pinto, Ilidio Rodrigues, Carlos Oliveira, Anibal Ferreira, Pedro Ponce
Centre: Fresenius Medical Care Portugal

Poster most viewed in this topic
Poster: 60
Visits: 24
Title: DETERMINING TREATMENT PREFERENCE FOR TOLVAPTAN IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD): DEVELOPMENT OF A DISCRETE CHOICE EXPERIMENT (DCE) FOR USE AS A CLINICAL STUDY ENDPOINT
Authors: Jennifer Quinn , Helen Doll, Paul Robinson, Hannah Lewis
Centre: Otsuka Pharmaceuticals


 






PosterSessionOnline
Logo Draft
 
Logo Cert